Stock Information
Janux Therapeutics Inc (JANX)
Ticker Symbol: JANX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $892.59 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -1.8334
Revenue (TTM): $0.16 M
Dividend Yield: N/A%
ROE: -11.55%
Latest News
-
Piper Sandler Maintains Overweight on Janux Therapeutics, Lowers Price Target to $26
Fri, May 8, 2026 11:07 AM
-
Wedbush Maintains Outperform on Janux Therapeutics, Lowers Price Target to $36
Fri, May 8, 2026 9:51 AM
-
Guggenheim Maintains Buy on Janux Therapeutics, Lowers Price Target to $58
Fri, May 8, 2026 8:58 AM
-
Janux Therapeutics Reports First Quarter 2026 Financial Results and Business Highlights
Thu, May 7, 2026 4:03 PM
-
Undercovered Dozen: Western Digital, SAP, Toast, And More
Mon, May 4, 2026 10:03 PM
-
Janux Therapeutics: Strong Buy As Pipeline Advances, Stock Trades Below Cash Value
Mon, May 4, 2026 7:33 PM
Key Financials
Financial data not available
